5,6-dihydro-4H-cyclopenta[b]thiophene | 5650-50-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 5,6-dihydro-4H-cyclopenta[b]thiophene
• CAS: 5650-50-0
• 化学式: C₇H₈S
• mdl: MFCD18451830
• 分子量: 124.207
• InChiKey: IRPQLEYYDURDBA-UHFFFAOYSA-N

物化性质

• 沸点：
  185.9±9.0 °C(Predicted)
• 密度：
  1.149±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5,6-dihydro-4H-cyclopenta[b]thiophene 在 氯磺酸 作用下， 以 氯仿 为溶剂， 反应 0.5h， 生成 5,6-Dihydro-4H-cyclopenta[b]thiophene-2-sulfonyl chloride
  参考文献：
  名称：

  Sulfonylureas: a new class of cancer chemotherapeutic agents

  摘要：

  This study summarizes the antitumor properties of a number of sulofenur thiophene analogs against subcutaneously implanted 6C3HED lymphosarcoma with structural modification of the aryl moiety of the sulfonamide portion of the diarylsulfonylureas. The spectrum of activity of N-(p-chlorophenyl)-N'-[(5-methoxy-2-thienyl)sulfonyl]urea in the HXGC3, VRC5, CX-1, and LX-1 cell lines is also presented.

  DOI：

  10.1021/jm00094a013
• 作为产物：
  描述：

  3-甲基噻吩 在 盐酸 、 sodium hydroxide 、 N-溴代丁二酰亚胺(NBS) 、 三氯化铝 、 氯化亚砜 、 溴 、 sodium hydride 、 溶剂黄146 、 肼 、 锌 作用下， 以 四氯化碳 、 氯仿 为溶剂， 生成 5,6-dihydro-4H-cyclopenta[b]thiophene
  参考文献：
  名称：

  Garreau, R.; Roncali, J.; Garnier, F., Journal de Chimie Physique et de Physico-Chimie Biologique, 1989, vol. 86, # 1, p. 93 - 98

  摘要：

  DOI：

文献信息

• DERIVATIVES OF IMIDAZO PYRIMIDO AND DIAZEPINE PYRIMIDINE-DIONE, AND USE THEREOF AS A DRUG
  申请人：Poitout Lydie

  公开号：US20100144714A1

  公开（公告）日：2010-06-10

  The present invention relates to new derivatives of imidazo, pyrimido and diazepine-pyrimidine-dione of the general formula (I) in which R 1 , R 2 , L 1 , L 2 , Y, Z and A are various and varying groups. These products exhibit a good affinity for certain sub-types of cannabinoid receptors, in particular the CB2 receptors. They are particularly useful for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said products, and to the use thereof for preparing a drug.

  本发明涉及通式（I）中的新咪唑，嘧啶和二氮杂吡咯啉-嘧啶二酮衍生物，其中R1，R2，L1，L2，Y，Z和A是各种不同的基团。这些产物对特定类型的大麻素受体，特别是CB2受体具有良好的亲和力。它们特别适用于治疗涉及一个或多个大麻素受体的病理状况和疾病。该发明还涉及含有上述产物的药物组合物，以及用于制备药物的使用。
• FUNGICIDAL ISOXAZOLIDINES
  申请人：TSENG CHI-PING

  公开号：US20090270407A1

  公开（公告）日：2009-10-29

  Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein A, B, D, R 1 , R 2 , R 3 , X and m are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  公开的是Formula 1的化合物，包括所有的几何和立体异构体、N-氧化物和盐， 其中 A、B、D、R 1 、R 2 、R 3 、X和m如披露中所定义。 还公开了含有Formula 1化合物的组合物，以及用于控制由真菌病原体引起的植物疾病的方法，包括施用本发明的化合物或组合物的有效量。
• [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2009062285A1

  公开（公告）日：2009-05-22

  Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

  式(I)的化合物：其中R4、R6和R7如本文所定义，可用作HIV复制的抑制剂。
• Heterocyclyl-substituted benzoylcyclohexandiones, their preparation, and their use as herbicides
  申请人：——

  公开号：US20020173424A1

  公开（公告）日：2002-11-21

  There are described benzoylcyclohexanediones of the formula I, their preparation, and their use as herbicides and plant growth regulators. 1 In this formula (I), R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R a , R b and R c are various radicals, and Y and Z are a monoatomic bridge element.

  该公式描述了式I的苯甲酰环己二酮，它们的制备以及它们作为除草剂和植物生长调节剂的用途。 在这个公式（I）中，R1，R2，R3，R4，R5，R6，R7，Ra，Rb和Rc是各种基团，Y和Z是单原子桥元素。
• C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF
  申请人：SHANGHAI DE NOVO PHARMATECH CO. LTD.

  公开号：US20170037038A1

  公开（公告）日：2017-02-09

  This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.

  这项发明涉及一种C-芳基糖苷衍生物，其药物组合物、制备方法及其用途。制备方法包括：方法1：在溶剂中，在碱的存在下去保护化合物1-f的乙酰保护基；方法2：1）化合物2-g通过Mitsunobu反应发生反应；2）去除从步骤1得到的化合物2-f的乙酰保护基；方法3：1）化合物2-g通过亲核取代反应发生反应；2）去除从步骤1得到的化合物3-f的乙酰保护基。药物组合物包括一种C-芳基糖苷衍生物；其药学上可接受的盐和/或前药以及赋形剂。这项发明还涉及一种C-芳基糖苷衍生物，其药学上可接受的盐或其药物组合物，用于制备SGLT抑制剂。这项发明的C-芳基糖苷衍生物为SGLT抑制剂的研究提供了新的方向。